Propanc Biopharma Financials

We recommend to use Propanc Biopharma fundamental analysis to find out if markets are presently mispricing the firm. Put it differently this technique allows you to confirm available drivers of Propanc Biopharma as well as the relationship between them. We have analyzed seventeen available financial ratios for Propanc Biopharma, which can be compared to its competitors.
  
Understanding current and past Propanc Biopharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Propanc Biopharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Propanc Biopharma's assets may result in an increase in income on the income statement.
Please note, the presentation of Propanc Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Propanc Biopharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Propanc Biopharma's management manipulating its earnings.

Propanc Biopharma Stock Summary

Propanc Biopharma competes with BioRestorative Therapies. Propanc Biopharma, Inc., a development-stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Propanc Biopharma, Inc. was founded in 2007 and is based in Camberwell, Australia. Propanc Biopharma operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business Address302, 6 Butler
SectorHealthcare
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.propanc.com
Phone61 3 9882 0780
CurrencyUSD - US Dollar

Propanc Biopharma Key Financial Ratios

There are many critical financial ratios that Propanc Biopharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Propanc Biopharma reports annually and quarterly.

Propanc Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Propanc Biopharma's current stock value. Our valuation model uses many indicators to compare Propanc Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Propanc Biopharma competition to find correlations between indicators driving Propanc Biopharma's intrinsic value. More Info.
Propanc Biopharma is rated top company in current valuation category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about  0.52  of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Propanc Biopharma is roughly  1.91 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Propanc Biopharma's earnings, one of the primary drivers of an investment's value.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Propanc Pink Sheet

If you are still planning to invest in Propanc Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Propanc Biopharma's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Directory
Find actively traded commodities issued by global exchanges